Pegcetacoplan, a new treatment for macular degeneration – Science-Based Medicine
The context is analogous to a pair of drugs recently approved for Alzheimer’s disease. Aducanumab (Aduhelm) was FDA approved for treatment of …
» Read moreThe context is analogous to a pair of drugs recently approved for Alzheimer’s disease. Aducanumab (Aduhelm) was FDA approved for treatment of …
» Read moreNew Jersey, USA- The rising technology in Asthma & COPD Market is also depicted in this research report. Factors that are boosting the growth of …
» Read moreIt’s important to get your coronary artery calcium (CAC) score if you multiple heart attack risk factors. Listen to this article.
» Read moreRegular physical activity is known to offer numerous health benefits, such as improved cardiovascular health, weight management, and stress reduction.
» Read moreLung cancer is the form of the disease that causes the most deaths, with approximately 1.8 million fatalities every year worldwide.
» Read more5W1H won the creative and digital mandate for Accu-Chek, blood glucose monitoring device by Roche Diabetes Care.
» Read moreTiny video capsule shows promise as an alternative to endoscopy … New drug to stop deadly brain cancer from worsening shows promise.
» Read moreExploring the risk factors related to severe OSA in obese patients including pulmonary ventilation function, diffusion function, and IOS data.
» Read moreThe study, presented at the British Cardiovascular Society (BCS) conference in Manchester, UK, found that the likelihood of a heart attack occurring …
» Read moreRegular Exercise. Physical activity is necessary because it helps in the process of bone and muscle strengthening. In older adults, exercise might not …
» Read moreA test based on seven chemicals found in uterine fluid outperformed the leading tool for diagnosing early-stage ovarian cancer – a disease that is …
» Read moreA peripheral nerve stimulator is a novel treatment option for QTR. … regarding femoral PNS as an alternative to traditional treatments for …
» Read more